New private equity fund seeks mid-sized businesses to invest and internationalize
This article was originally published in Clinica
Fresh from sealing its maiden deal, GHO Capital is now looking to invest in more “mid-market, growing, profitable companies” within medtech, biopharma and B2B services.
You may also be interested in...
Private Company Edition: GHO Capital will invest €975m in pharmaceutical and other opportunities in Europe, but Wellington’s $393m fund is focused on drug discovery and development. Also, Avidity raises $100m and Werewolf launches with $56m.
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.